ABCB2 p.Glu3Ser
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 17068338
[PubMed]
Perria CL et al: "Catalytic site modifications of TAP1 and TAP2 and their functional consequences."
No.
Sentence
Comment
313
These include ABCC1-6 and ABCC10-11 (multidrug resistance proteins), ABCC8 and ABCC9 (SUR1 and SUR2) that all contain Walker B Glu 3 Asp substitutions in their NBD1, and NBD1 of ABCC7 (cystic fibrosis transmembrane conductance regulator, which has a Walker B Glu 3 Ser substitution).
X
ABCB2 p.Glu3Ser 17068338:313:259
status: NEW312 These include ABCC1-6 and ABCC10-11 (multidrug resistance proteins), ABCC8 and ABCC9 (SUR1 and SUR2) that all contain Walker B Glu 3 Asp substitutions in their NBD1, and NBD1 of ABCC7 (cystic fibrosis transmembrane conductance regulator, which has a Walker B Glu 3 Ser substitution).
X
ABCB2 p.Glu3Ser 17068338:312:259
status: NEW310 These include ABCC1-6 and ABCC10-11 (multidrug resistance proteins), ABCC8 and ABCC9 (SUR1 and SUR2) that all contain Walker B Glu 3 Asp substitutions in their NBD1, and NBD1 of ABCC7 (cystic fibrosis transmembrane conductance regulator, which has a Walker B Glu 3 Ser substitution).
X
ABCB2 p.Glu3Ser 17068338:310:259
status: NEW